Table of Contents

January 1997; 46 (1)

Select this article
- G Boden
Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.
Diabetes January 1997 46:3-10; doi:10.2337/diabetes.46.1.3
- Abstract
Select this article
- N Hariharan,
- D Farrelly,
- D Hagan,
- D Hillyer,
- C Arbeeny,
- T Sabrah,
- A Treloar,
- K Brown,
- S Kalinowski,
- and K Mookhtiar
Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight.
Diabetes January 1997 46:11-16; doi:10.2337/diabetes.46.1.11
- Abstract
Select this article
- C Sutherland,
- P W Tebbey,
- and D K Granner
Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells.
Diabetes January 1997 46:17-22; doi:10.2337/diabetes.46.1.17
- Abstract
Select this article
- T J Allen,
- M J Waldron,
- D Casley,
- G Jerums,
- and M E Cooper
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
Diabetes January 1997 46:19-24; doi:10.2337/diabetes.46.1.19
- Abstract
Select this article
- D M Kendall,
- A U Teuscher,
- and R P Robertson
Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans.
Diabetes January 1997 46:23-27; doi:10.2337/diabetes.46.1.23
- Abstract
Select this article
- V Gupta,
- D C Wahoff,
- D P Rooney,
- V Poitout,
- D E Sutherland,
- D M Kendall,
- and R P Robertson
The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined.
Diabetes January 1997 46:28-33; doi:10.2337/diabetes.46.1.28
- Abstract
Select this article
- M B French,
- J Allison,
- D S Cram,
- H E Thomas,
- M Dempsey-Collier,
- A Silva,
- H M Georgiou,
- T W Kay,
- L C Harrison,
- and A M Lew
Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.
Diabetes January 1997 46:34-39; doi:10.2337/diabetes.46.1.34
- Abstract
Select this article
- B Zhang,
- M S Lan,
- and A L Notkins
Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.
Diabetes January 1997 46:40-43; doi:10.2337/diabetes.46.1.40
- Abstract
Select this article
- R Stöcklin,
- L Vu,
- L Vadas,
- F Cerini,
- A D Kippen,
- R E Offord,
- and K Rose
A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry.
Diabetes January 1997 46:44-50; doi:10.2337/diabetes.46.1.44
- Abstract
Select this article
- V N Civelek,
- J T Deeney,
- G E Fusonie,
- B E Corkey,
- and K Tornheim
Oscillations in oxygen consumption by permeabilized clonal pancreatic beta-cells (HIT) incubated in an oscillatory glycolyzing muscle extract: roles of free Ca2+, substrates, and the ATP/ADP ratio.
Diabetes January 1997 46:51-56; doi:10.2337/diabetes.46.1.51
- Abstract
Select this article
- M M Hennes,
- A Dua,
- and A H Kissebah
Effects of free fatty acids and glucose on splanchnic insulin dynamics.
Diabetes January 1997 46:57-62; doi:10.2337/diabetes.46.1.57
- Abstract
Select this article
- S M Haffner,
- G Howard,
- E Mayer,
- R N Bergman,
- P J Savage,
- M Rewers,
- L Mykkänen,
- A J Karter,
- R Hamman,
- and M F Saad
Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.
Diabetes January 1997 46:63-69; doi:10.2337/diabetes.46.1.63
- Abstract
Select this article
- D G Maggs,
- R Jacob,
- F Rife,
- S Caprio,
- W V Tamborlane,
- and R S Sherwin
Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue.
Diabetes January 1997 46:70-76; doi:10.2337/diabetes.46.1.70
- Abstract
Select this article
- R Sipiläinen,
- M Uusitupa,
- S Heikkinen,
- A Rissanen,
- and M Laakso
Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns.
Diabetes January 1997 46:77-80; doi:10.2337/diabetes.46.1.77
- Abstract
Select this article
- G Desideri,
- C Ferri,
- C Bellini,
- G De Mattia,
- and A Santucci
Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies.
Diabetes January 1997 46:81-86; doi:10.2337/diabetes.46.1.81
- Abstract
Select this article
- I W Bobbink,
- H C de Boer,
- W L Tekelenburg,
- J D Banga,
- and P G de Groot
Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin.
Diabetes January 1997 46:87-93; doi:10.2337/diabetes.46.1.87
- Abstract
Select this article
- J R Nyengaard,
- K Chang,
- S Berhorst,
- K M Reiser,
- J R Williamson,
- and R G Tilton
Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
Diabetes January 1997 46:94-106; doi:10.2337/diabetes.46.1.94
- Abstract
Select this article
- J P Vora,
- T T Oyama,
- M M Thompson,
- and S Anderson
Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.
Diabetes January 1997 46:107-112; doi:10.2337/diabetes.46.1.107
- Abstract
Select this article
- R C Hicks,
- J Moss,
- D J Higman,
- R M Greenhalgh,
- and J T Powell
The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.
Diabetes January 1997 46:113-118; doi:10.2337/diabetes.46.1.113
- Abstract
Select this article
- B L Vergès,
- L Lagrost,
- G Vaillant,
- J M Petit,
- M Cohen,
- P Gambert,
- and J M Brun
Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Diabetes January 1997 46:125-132; doi:10.2337/diabetes.46.1.125
- Abstract
Select this article
- N Sato,
- K Kashima,
- Y Tanaka,
- H Shimizu,
- and M Mori
Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.
Diabetes January 1997 46:133-137; doi:10.2337/diabetes.46.1.133
- Abstract
Select this article
- R Morishita,
- S Nakamura,
- Y Nakamura,
- M Aoki,
- A Moriguchi,
- I Kida,
- Y Yo,
- K Matsumoto,
- T Nakamura,
- J Higaki,
- and T Ogihara
Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.
Diabetes January 1997 46:138-142; doi:10.2337/diabetes.46.1.138
- Abstract
Select this article
- D E Undlien,
- T Friede,
- H G Rammensee,
- G Joner,
- K Dahl-Jørgensen,
- O Søvik,
- H E Akselsen,
- I Knutsen,
- K S Rønningen,
- and E Thorsby
HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.
Diabetes January 1997 46:143-149; doi:10.2337/diabetes.46.1.143
- Abstract
Select this article
- R J Jacob,
- J Dziura,
- M B Medwick,
- P Leone,
- S Caprio,
- M During,
- G I Shulman,
- and R S Sherwin
The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.
Diabetes January 1997 46:150-152; doi:10.2337/diabetes.46.1.150
- Abstract
Select this article
- D Massillon,
- N Barzilai,
- M Hawkins,
- D Prus-Wertheimer,
- and L Rossetti
Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion.
Diabetes January 1997 46:153-157; doi:10.2337/diabetes.46.1.153
- Abstract

Current Issue

February 2012, 61 (2)

Print ISSN: 0012-1797
Online ISSN: 1939-327X

Diabetes

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

Expression of human hepatic glucokinase in transgenic mice liver results in decreased glucose levels and reduced body weight.

Oxidative and chemical stress mimic insulin by selectively inhibiting the expression of phosphoenolpyruvate carboxykinase in hepatoma cells.

Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.

Defective glucagon secretion during sustained hypoglycemia following successful islet allo- and autotransplantation in humans.

The defective glucagon response from transplanted intrahepatic pancreatic islets during hypoglycemia is transplantation site-determined.

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.

Autoantibodies to IA-2 in IDDM: location of major antigenic determinants.

A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry.

Oscillations in oxygen consumption by permeabilized clonal pancreatic beta-cells (HIT) incubated in an oscillatory glycolyzing muscle extract: roles of free Ca2+, substrates, and the ATP/ADP ratio.

Effects of free fatty acids and glucose on splanchnic insulin dynamics.

Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.

Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue.

Polymorphism of the beta3-adrenergic receptor gene affects basal metabolic rate in obese Finns.

Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion: in vitro and in vivo studies.

Effect of extracellular matrix glycation on endothelial cell adhesion and spreading: involvement of vitronectin.

Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.

Interactions of the kallikrein-kinin and renin-angiotensin systems in experimental diabetes.

The influence of diabetes on the vasomotor responses of saphenous vein and the development of infra-inguinal vein graft stenosis.

Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.

Effect of granulocyte-colony stimulating factor on generation of oxygen-derived free radicals and myeloperoxidase activity in neutrophils from poorly controlled NIDDM patients.

Potential role of an endothelium-specific growth factor, hepatocyte growth factor, on endothelial damage in diabetes.

HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection.

The effect of leptin is enhanced by microinjection into the ventromedial hypothalamus.

Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion.

This Issue

Current Issue